FOR ORGANIZATIONS

Bring reviewable medicine information to more readers.

OriginDrug can discuss traceable bilingual medicine materials, source-update maintenance and embedding assessment with public-information services. Public pages remain free and editorially neutral; collaboration does not alter topic selection, source standards or public conclusions.

Complete the five-fact enquiryView field dictionary and data servicesComplete the procurement scope

START BY BUYER SCENARIO

Choose the procurement path closest to your team

Health-tech and medicine-content teamsA 20-record, one-market bilingual core-field pilot delivered as JSON and XLSX.Review the data pilot →Pharmacy and patient-education teamsOne real medicine page accepted in Chinese/English, mobile, keyboard and three text sizes.Review the page pilot →

Inspect a real deliverable first

No information needs to be submitted first. Review how one published dossier is represented on the human-readable page, in the structured interface and under the editorial rules.

Three deliverables we can discuss

Bilingual medicine materials
For: public-information, patient-education and research-support teams.
Deliverable: agreed brand/generic names, dosage form, market, primary sources, review date and machine-readable fields.
Scoping basis: medicine count, markets, languages, field depth and licence boundaries; pricing remains subject to final financial confirmation.
Source-update maintenance
For: organizations with existing medicine content that needs continuing source and version review.
Deliverable: link health, document versions, review records and change logs for the agreed scope.
Scoping basis: medicines, source count, review frequency, response level and format; pricing remains subject to final financial confirmation.
Embedding and accessibility assessment
For: teams displaying sourced medicine material in existing sites, education materials or service flows.
Deliverable: field mapping, source/date/market display, reading-size, keyboard and mobile-accessibility assessment.
Scoping basis: page/API scope, target platforms, languages and acceptance depth; pricing remains subject to final financial confirmation.

PAID PILOT OPTIONS

Start with a bounded, reviewable pilot

Each pilot freezes the medicine list, markets, fields, sources, version and acceptance criteria before work begins. Pricing is confirmed only after scope review; no public medicine ranking or editorial conclusion can be purchased.

Evidence data pilot

Best for
For patient-information, pharmacy, insurance and health-technology teams validating a structured evidence feed.
Minimum starting scope
One-off data pilot starting with 20 records
Scope baseline
A named set of medicines, target markets and bilingual fields agreed in writing.
Pilot deliverables
Field dictionary, sample JSON/XLSX delivery, source register, content revision and exception log.
Acceptance evidence
Required fields present; every factual field returns to its agreed source and market; exceptions are explicitly listed.

Source-change monitoring pilot

Best for
For teams that already maintain medicine content and need a controlled update watchlist.
Minimum starting scope
Monthly review of 20 medicine × market × source combinations
Scope baseline
A named medicine × market × source watchlist with an agreed review frequency.
Pilot deliverables
Link-health record, version comparison, dated change register and review summary.
Acceptance evidence
Every reported change identifies the previous and current source, review date, affected field and unresolved question.

Embedding and accessibility pilot

Best for
For websites or public-information services assessing reuse of source-linked medicine content.
Minimum starting scope
Bilingual mobile acceptance for one real page workflow
Scope baseline
A named page or component set, target devices, languages and accessibility checks.
Pilot deliverables
Field mapping, display-boundary specification, keyboard/mobile/text-size review and implementation findings.
Acceptance evidence
The agreed workflow is operable on target devices and preserves source, market, date and safety boundaries.

CONTINUING SERVICE

Move from a pilot to a reviewable maintenance rhythm

These are scope patterns, not fixed-price plans. The medicine list, markets, sources, review windows, deliverables, acceptance evidence and response boundary must be agreed in writing before service begins.

Quarterly evidence maintenance

Review rhythm
Scheduled review once per quarter
Included evidence work
Review agreed source links and document versions; issue a dated change register, exception list and content-revision summary.
Best fit
For a stable published medicine set that needs periodic evidence maintenance rather than continuous surveillance.

Monthly source monitoring

Review rhythm
Scheduled review once per month
Included evidence work
Review the agreed medicine × market × source watchlist; identify version or link changes and place material items into a priority review queue.
Best fit
For services with a higher update cadence and a defined source watchlist. It is not real-time safety monitoring.

Event-driven review add-on

Review rhythm
Review after an agreed official-source trigger
Included evidence work
Assess the named official notice or label update, record affected fields and unresolved questions, and issue an auditable update note.
Best fit
For organizations that need a bounded response workflow around defined regulatory or label events.

Fees, taxes, source licences, delivery windows, support level, SLA and renewal terms remain subject to a mutually confirmed written scope and final financial confirmation.

Shared basis for delivery and acceptance

Every collaboration should identify the covered medicines, target markets, primary sources, review dates, licence limits, language versions and update arrangements. Public accessibility does not mean a source can be freely republished or applies in every market. Source permissions, copyright, trademark use, medical-content review and target-market compliance must be confirmed individually before work begins.

Editorial independence and data boundary

No collaborator can purchase, direct or alter OriginDrug’s editorial conclusions, inclusion criteria or safety boundary. Do not send medical records, prescriptions, pack photographs, medicine lists or other identifiable health information as part of a collaboration enquiry. If a future service needs to process data, its purpose, data minimisation, storage, access controls and applicable-law review will be completed before that service begins.

How collaboration scope stays clear

Current discussions cover public medicine-information organization, source maintenance and accessible presentation. Medicine sales, procurement, delivery, recommendations, prescription routing, diagnosis, individual advice, patient recruitment, advertising, affiliate referrals and a public price list remain outside scope. Every project is governed by mutually confirmed written scope, deliverables and acceptance criteria.

Start a collaboration enquiry

Please state your organization type, the public scenario you support, target markets, the material scope you want to discuss and your intended timing. Do not email personal health information, medical records, prescriptions, identity documents or payment information.

  1. Describe the scenario: identify the readers, target market and public-information use.
  2. Bound the scope: list medicine count, required fields, languages and timing so sources and licence limits can be reviewed item by item.
  3. Document the scope: a project discussion proceeds only after deliverables, review method, responsibility boundaries and acceptance criteria are explicit.
  4. Accept and maintain: acceptance uses agreed samples, fields, source lists and review dates; later updates follow a separately documented scope.

SCOPE BUILDER

Turn your scope into a reviewable enquiry

Start with five essentials: organization or website, work email, intended use, target market and an approximate medicine scope. Optional details can be agreed after OriginDrug returns a scope suggestion. This page prepares a copyable summary or email draft; opening a draft does not send it.

Fill a minimum pilot scope in one click

Choose the closest starting point. We fill empty fields and update unedited suggestions, while keeping your edits and the medicine carried from its record. Add the organization, work email and target market, then review the draft.

Do not enter patient names, medicine lists, prescriptions, pack photographs, medical records, identity documents or payment information.

Priority is derived only from the selected procurement stage. It is local commercial triage, not medical or personal profiling.

The verified delivery path is to prepare the scope here and then open a draft in your email application. You must review and send that draft; unsent form content is not uploaded to OriginDrug servers. If the email application does not open, download the scope text and send it to stevenyiqingli@foxmail.com, contact Steven Li.

Please also read the editorial policy, privacy policy and terms.

Search records
Enlarged public-label image